JDP MEDICAL LIMITED 16236403 false 2025-02-07 2026-03-31 2026-03-31 The principal activity of the company is private medical services Digita Accounts Production Advanced 6.30.9574.0 true 16236403 2025-02-07 2026-03-31 16236403 2026-03-31 16236403 core:CurrentFinancialInstruments core:WithinOneYear 2026-03-31 16236403 bus:Micro-entities 2025-02-07 2026-03-31 16236403 bus:AuditExemptWithAccountantsReport 2025-02-07 2026-03-31 16236403 bus:FullAccounts 2025-02-07 2026-03-31 16236403 bus:SmallCompaniesRegimeForAccounts 2025-02-07 2026-03-31 16236403 bus:RegisteredOffice 2025-02-07 2026-03-31 16236403 bus:Director1 2025-02-07 2026-03-31 16236403 bus:Director2 2025-02-07 2026-03-31 16236403 bus:PrivateLimitedCompanyLtd 2025-02-07 2026-03-31 16236403 bus:Agent1 2025-02-07 2026-03-31 16236403 countries:England 2025-02-07 2026-03-31 iso4217:GBP xbrli:pure

Registration number: 16236403

JDP MEDICAL LIMITED

Annual Report and Unaudited Financial Statements

for the Period from 7 February 2025 to 31 March 2026

 

JDP MEDICAL LIMITED

Contents

Company Information

1

Balance Sheet

2

Notes to the Unaudited Financial Statements

2

 

JDP MEDICAL LIMITED

Company Information

Directors

Dr J Patch

Dr E Patch

Registered office

13 Lampeter Road
Bristol
BS9 3QQ

Accountants

hcl chartered accountants 32 Henbury Road
Westbury-on-Trym
Bristol
BS9 3NQ

 

JDP MEDICAL LIMITED

(Registration number: 16236403)
Balance Sheet as at 31 March 2026

2026
£

Current assets

75,718

Creditors: Amounts falling due within one year

(19,641)

Total assets less current liabilities

56,077

Accruals and deferred income

(650)

 

55,427

Capital and reserves

55,427

1

General information

The company is a private company limited by share capital, incorporated in England.

The address of its registered office is:
13 Lampeter Road
Bristol
BS9 3QQ

These financial statements were authorised for issue by the Board on 23 September 2026.

2

Staff numbers

The average number of persons employed by the company (including directors) during the period, was 1.

For the financial period ending 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

•

The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476; and

•

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the micro entities regime and FRS 105 ‘The Financial Reporting Standard Applicable to the Micro-entities Regime.

Approved and authorised by the Board on 23 September 2026 and signed on its behalf by:
 

.........................................
Dr J Patch
Director